In the study of Brettschneider et al., the sensitivity for predicting conversion to clinically definite (CD) MS after CIS was generally low, but could be increased by combining MRI with CSF NF-H criteria [25]. The gene discussed is NEFH; the disease is myeloid sarcoma.